The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.

SUMO: Generating Multi-Omics Datasets for Testing and Benchmarking

Provides tools to simulate multi-omics datasets with predefined signal structures. The generated data can be used for testing, validating, and benchmarking integrative analysis methods such as factor models and clustering approaches. This version includes enhanced signal customization, visualization tools (scatter, histogram, 3D), MOFA-based analysis pipelines, PowerPoint export, and statistical profiling of datasets. Designed for both method development and teaching, SUMO supports real and synthetic data pipelines with interpretable outputs. Tini, Giulia, et al (2019) <doi:10.1093/bib/bbx167>.

Version: 0.2.0
Imports: ggplot2, gridExtra, rlang, stats, graphics, utils, dplyr, readr, readxl, stringr, data.table, magrittr, officer
Suggests: testthat (≥ 3.0.0), MOFAdata, MOFA2, rvg, fabia, tidyverse, grid, basilisk
Published: 2025-04-13
DOI: 10.32614/CRAN.package.SUMO
Author: Bernard Isekah Osang'ir ORCID iD [aut, cre], Ziv Shkedy [ctb], Surya Gupta [ctb], Jürgen Claesen [ctb]
Maintainer: Bernard Isekah Osang'ir <Bernard.Osangir at sckcen.be>
License: CC BY 4.0
NeedsCompilation: no
Materials: NEWS
CRAN checks: SUMO results

Documentation:

Reference manual: SUMO.pdf

Downloads:

Package source: SUMO_0.2.0.tar.gz
Windows binaries: r-devel: SUMO_0.2.0.zip, r-release: SUMO_0.2.0.zip, r-oldrel: SUMO_0.2.0.zip
macOS binaries: r-release (arm64): SUMO_0.2.0.tgz, r-oldrel (arm64): SUMO_0.2.0.tgz, r-release (x86_64): SUMO_0.2.0.tgz, r-oldrel (x86_64): SUMO_0.2.0.tgz
Old sources: SUMO archive

Linking:

Please use the canonical form https://CRAN.R-project.org/package=SUMO to link to this page.

These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.